Evidence map›Paper›PMID 23585580›Full record

ReviewBriefings in functional genomics2013

Epigenetic memory in the context of nuclear reprogramming and cancer.

Richard P Halley-Stott, John B Gurdon

Abstract readReview
In one paragraph

Review in Briefings in functional genomics, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Cattle Cloning by Somatic Cell Nuclear Transfer.Methods in molecular biology (Clifton, N.J.) · 2023
    Article
  7. Article
  8. Article
  9. Drug Repurposing by Tumor Tissue Editing.Frontiers in oncology · 2022
    Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Stem cells and reproduction.BMB reports · 2019
    Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. DNA methylation: an epigenetic mark of cellular memory.Experimental & molecular medicine · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Richard P Halley-StottThe Wellcome Trust/Cancer Research UK Gurdon Institute, University of Cambridge, Tennis Court Road, Cambridge, CB2 1QN United Kingdom.
John B Gurdon

Funding

Biotechnology and Biological Sciences Research Council BBS/B/14647Medical Research Council G1001690Wellcome Trust 092096
6 · The paper itself

Abstract

Epigenetic memory represents a natural mechanism whereby the identity of a cell is maintained through successive cell cycles, allowing the specification and maintenance of differentiation during development and in adult cells. Cancer is a loss or reversal of the stable differentiated state of adult cells and may be mediated in part by epigenetic changes. The identity of somatic cells can also be reversed experimentally by nuclear reprogramming. Nuclear reprogramming experiments reveal the mechanisms required to activate embryonic gene expression in adult cells and thus provide insight into the reversal of epigenetic memory. In this article, we will introduce epigenetic memory and the mechanisms by which it may operate. We limit our discussion primarily to the context of nuclear reprogramming and briefly discuss the relevance of memory and reprogramming to cancer biology.

Indexed as

AnimalsCellular ReprogrammingDNA MethylationEpigenesis, GeneticHumansNeoplasmscancerDNA methylationepigenetic memoryhistone modificationsnuclear reprogramming

Identifiers

PMID23585580
PMCPMC3662891

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.